India faces a rising burden of blood cancers, with around 120,000 new cases and over 70,000 deaths annually from leukemia, ...

India’s first global CAR T-cell therapy for adult B-cell Non-Hodgkin Lymphoma (B-NHL), a kind of blood cancer that affects ...

Hannah Riddell (pictured) finished school at Ashington Academy last summer and had plans to start a travel and tourism course ...

Immuneel Therapeutics introduces Qartemi, India's first personalised CAR T-cell therapy for B-NHL, offering affordable ...

Our Bureau, Bengaluru Monday, January 20, 2025, 14:30 Hrs [IST] ...

The approval of Calquence marks the first and only BTK inhibitor approved for the first-line treatment of MCL in the US.

Immuneel Therapeutics, the start-up, backed by Kiran Mazumdar-Shaw, was the first in India to conduct CAR T-cell therapy ...

A Johnstone student is supporting young people to speak more openly about their cancer experiences as he takes part in a ...

Dave Coulier is bravely battling stage 3 non-Hodgkin lymphoma, using humor to cope with the tough journey, including joking ...

In what it describes as a significant step forward for India’s cancer treatment, India’s cell and gene therapy start-up ...

Therapy will cost Rs 35 to 50 lakh. India sees around 1.20 lakh new blood cancer cases and over 70,000 deaths annually from ...

The therapy can cost anywhere between $350,000 and $700,000 globally. While Immuneel has brought it down to about ₹51 lakh to ...